MHRAsafety guidance72% confidence
Project Orbis
Source: MHRA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (liver cancer) as Imfinzi+Imjudo shows significant PFS improvement in early liver cancer trial.
Regulatory Analysis
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Supporting Context
- Therapeutic area
- Oncology · Liver Cancer
- Sub-indication
- Liver Cancer
Related signal: Imfinzi+Imjudo shows significant PFS improvement in early liver cancer trial